Abstract
Multiple sclerosis (MS) is a devastating disease which needs to be treated early in the neurodegeneration process. Numerous effective therapies are available and need to be selected based on various patient factors, including disease severity. Managed care can have a role in managing adherence with disease-modifying therapies and overall costs by eliminating barriers to DMT use.
Original language | English (US) |
---|---|
Pages (from-to) | 51-55 |
Number of pages | 5 |
Journal | Journal of Managed Care Medicine |
Volume | 25 |
Issue number | 1 |
State | Published - 2022 |
ASJC Scopus subject areas
- Health Policy